Parkinson's drug safety trial halted early
Symptom relief
Terminated
This early-stage study tested a new drug called talineuren in 22 people with Parkinson's disease. The goal was to see if it is safe to give through a vein. The study was stopped early, and it focused on safety, not on curing the disease.
Phase: PHASE1 • Sponsor: InnoMedica Schweiz AG • Aim: Symptom relief
Last updated May 26, 2026 11:37 UTC